Neurological condition facts
While commonly associated with the brain, complex neurological conditions affect the spinal cord, nerves and muscles as well1.
More than 100 million Americans have been diagnosed with a neurological condition2, including migraines and epilepsy.
More than $20,000 spent by plan sponsors per epilepsy patient per year3.
What is the Neurological Care Value Program?
Uniquely designed to address the brain and beyond, the Neurological Care Value® Program, part of the SafeGuardRx® platform, delivers enhanced care for your members who suffer from migraines and epilepsy as well as savings for your plan.
Clinical breakthroughs represent unique opportunities to provide financial and clinical support, beyond expectations and beyond what's on the market today.
Member Benefits
Guided support
New-to-therapy coaching, adherence monitoring and outreaches all provide additional clinical support for members from the Neuroscience Therapeutic Resource Center®.
Quality migraine care
Clinicians will educate physicians on acute and preventative treatment options to determine the most appropriate and effective therapy regimen for each patient.
Holistic focus
Uniquely designed to address the brain and beyond, with flexibility to add more neurological conditions in the future.
Plan Benefits
Financial protection
Cost savings on preferred preventative and acute neurological medications and early discontinuation reimbursements for preventative CGRP-inhibitor or maintenance epilepsy medications.
Reducing wasteful spend
Assurance that the right patients have the right medication. Through a tailored approach for your plan, we'll partner with members and their physicians to drive awareness around new therapy options while ensuring that only the right patients have access to Neurological Care Value Program products.
Frequently Asked Questions
-
What savings can plans expect by enrolling?
Through our negotiating power, clients pay less for preferred neurological products. We're also mitigating our clients' financial risk; if a preferred neurological product doesn't work for one of their members and they fall off therapy, we'll reimburse the plan.
Clients will see further savings in the future by driving to the lowest net-cost neurological medication through the National Preferred Formulary or utilization management tools. Additionally, a flat discount will be realized on all eligible utilization for preferred acute migraine products with an incremental increase in high utilizers.
-
How does the early discontinuation credit apply?
The early discontinuation credit applies to patients who are new to therapy (have not previously filled a preferred preventative product in 270 days) whose first fill is after the start date through discontinuation of therapy.
-
What is the value my members receive through support of the Neuroscience Therapeutic Resource Center?
The Neuroscience Therapeutic Resource Center provides members neurological products with specialized support, including:
- Coaching for new-to-therapy members on using an injectable medication for migraine preventative products and counseling for epilepsy preventative products
- Adherence monitoring
- Education on migraine triggers and disease states
- Special handling requirements for medication
- Proactive pharmacist outreach when non-adherence occurs to understand why it's happening, and to support patients with an appropriate treatment path
- Johns Hopkins Medicine. Overview of Nervous System Disorders.
- Myana.org. American Neurological Association Announces Winners of 2022 Awards for Outstanding Accomplishments in Academic Neurology and Neuroscience.
- National Library of Medicine. Cost of epilepsy-related health care encounters in the United States.